Disparities in cancer screenings for sexual and gender minorities

Boehmer, 2013, Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation?, J Cancer Surviv, 7, 203, 10.1007/s11764-012-0260-8 Dibble, 2004, Comparing breast cancer risk between lesbians and their heterosexual sisters, Womens Health Issues, 14, 60, 10.1016/j.whi.2004.03.004 Quinn, 2015, Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations, CA Cancer J Clin, 65, 384, 10.3322/caac.21288 Kates, 2018 2014, The health consequences of smoking—50 years of progress: a report of the Surgeon General Connor, 2017, Alcohol consumption as a cause of cancer, Addiction, 112, 222, 10.1111/add.13477 Jackson, 2021, Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States, J Natl Cancer Inst, 113, 1221, 10.1093/jnci/djab028 Gibson, 2017, Cancer care in lesbian, gay, bisexual, transgender and queer populations, Future Oncol, 13, 1333, 10.2217/fon-2017-0482 Sacca, 2019, Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants, J Genet Couns, 28, 708, 10.1002/jgc4.1046 Flentje, 2020, The relationship between minority stress and biological outcomes: A systematic review, J Behav Med, 43, 673, 10.1007/s10865-019-00120-6 Meyer, 2003, Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence, Psychol Bull, 129, 674, 10.1037/0033-2909.129.5.674 Boehmer, 2011, Comparing sexual minority cancer survivors recruited through a cancer registry to convenience methods of recruitment, Womens Health Issues, 21, 345, 10.1016/j.whi.2011.03.003 Deutsch, 2017, Breast cancer screening, management, and a review of case study literature in transgender populations, Semin Reprod Med, 35, 434, 10.1055/s-0037-1606103 von Vaupel-Klein, 2021, Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles, J Genet Couns, 30, 98, 10.1002/jgc4.1372 Dimitrakakis, 2003, A physiologic role for testosterone in limiting estrogenic stimulation of the breast, Menopause, 10, 292, 10.1097/01.GME.0000055522.67459.89 Dorgan, 2010, Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk, Breast Cancer Res, 12, R98, 10.1186/bcr2779 Eigeliene, 2012, Androgens inhibit the stimulatory action of 17beta-estradiol on normal human breast tissue in explant cultures, J Clin Endocrinol Metab, 97, E1116, 10.1210/jc.2011-3228 Coad, 2021, Considerations in management for trans and gender diverse patients with inherited cancer risk, Current Genet Med Rep, 9, 59, 10.1007/s40142-021-00201-6 Legal, 2010 Blank, 2015, 99 Ceres, 2018, Cancer screening considerations and cancer screening uptake for lesbian, gay, bisexual, and transgender persons, Semin Oncol Nurs, 34, 37, 10.1016/j.soncn.2017.12.001 Bosworth, A., Turrini, G., Pyda, S., et al. Health insurance coverage and access to care for LGBTQ+ Individuals (Issue Brief No. HP-2021-14). 2021. Koma, 2020 Department of Health & Human Services. Nondiscrimination in Health Programs and Activities Proposed Rule U.S; 2015 Available from https://www.hhs.gov/civil-rights/for-individuals/section-1557/nondiscrimination-health-programs-and-activities-proposed-rule/index.html. Baker, 2017, The future of transgender coverage, N Engl J Med, 376, 1801, 10.1056/NEJMp1702427 Department of Health & Human Services. Nondiscrimination in Health Programs and Activities U.S; 2016 Available from https://www.federalregister.gov/documents/2016/05/18/2016-11458/nondiscrimination-in-health-programs-and-activities. Griggs, 2017, American society of clinical oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations, J Clin Oncol, 35, 2203, 10.1200/JCO.2016.72.0441 Stott, 2013, The training needs of general practitioners in the exploration of sexual health matters and providing sexual healthcare to lesbian, gay and bisexual patients, Med Teach, 35, 752, 10.3109/0142159X.2013.801943 Butler, 2016 Blas, 2010, Effect of an online video-based intervention to increase HIV testing in men who have sex with men in Peru, PLoS One, 5, e10448, 10.1371/journal.pone.0010448 Bachmann, 2013, Impact of a computer-assisted, provider-delivered intervention on sexual risk behaviors in HIV-positive men who have sex with men (MSM) in a primary care setting, AIDS Educ Prev, 25, 87, 10.1521/aeap.2013.25.2.87 2017, Practice bulletin number 179, Breast Cancer Risk Assessment Screen Average-Risk Women, 130, e1 2022, ACOG Committee Opinion No. 823, Health Care Transgender Gender Diverse Individuals: Correction, 139, 345 Stone, 2018, Breast cancer in transgender patients: A systematic review. Part 2: Female to Male, Eur J Surg Oncol, 44, 1463, 10.1016/j.ejso.2018.06.021 Puechl, 2019, Care and Cancer Screening of the Transgender Population, J Womens Health (Larchmt), 28, 761, 10.1089/jwh.2018.6945 Labanca, 2020, Transgender patients: considerations for routine gynecologic care and cancer screening, Int J Gynecol Cancer, 30, 1990, 10.1136/ijgc-2020-001860 Gooren, 2013, Breast cancer development in transsexual subjects receiving cross-sex hormone treatment, J Sex Med, 10, 3129, 10.1111/jsm.12319 Chlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial, JAMA, 289, 3243, 10.1001/jama.289.24.3243 Maycock, 2014, Breast care in the transgender individual, J Midwifery Womens Health, 59, 74, 10.1111/jmwh.12066 Kanhai, 2000, Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men, Am J Surg Pathol, 24, 74, 10.1097/00000478-200001000-00009 Fabris, 2015, Cross-sex hormone therapy for gender dysphoria, J Endocrinol Invest, 38, 269, 10.1007/s40618-014-0186-2 Hembree, 2009, Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 94, 3132, 10.1210/jc.2009-0345 Meyer, 1986, Physical and hormonal evaluation of transsexual patients: a longitudinal study, Arch Sex Behav, 15, 121, 10.1007/BF01542220 Perkins, 2019, ASCCP Risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors, J Low Genit Tract Dis, 24, 102, 10.1097/LGT.0000000000000525 Loud, 2017, Cancer screening and early detection in the 21(st) Century, Semin Oncol Nurs, 33, 121, 10.1016/j.soncn.2017.02.002 2000 2012, 525: Health care for lesbians and bisexual women, ACOG Committee Opinion No, 119, 1077 Buys, 2011, Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial, JAMA, 305, 2295, 10.1001/jama.2011.766 2015 Peitzmeier, 2014, Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening, J Gen Intern Med, 29, 778, 10.1007/s11606-013-2753-1 Feldman, 2008, Medical and surgical management of the transgender patient: What the primary care clinician needs to know, 365 Sevelius, 2013, Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color, Sex Roles, 68, 675, 10.1007/s11199-012-0216-5 Dutton, 2008, Gynecologic care of the female-to-male transgender man, J Midwifery Womens Health, 53, 331, 10.1016/j.jmwh.2008.02.003 Grimstad, 2019, Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series, Am J Obstet Gynecol, 220, 257, 10.1016/j.ajog.2018.12.021 Bibbins-Domingo, 2017, The US preventive services task force 2017 draft recommendation statement on screening for prostate cancer: an invitation to review and comment, JAMA, 317, 1949, 10.1001/jama.2017.4413 Ma, 2021, Prostate cancer screening patterns among sexual and gender minority individuals, Eur Urol, 79, 588, 10.1016/j.eururo.2020.11.009 Tabaac, 2018, Gender identity disparities in cancer screening behaviors, Am J Prev Med, 54, 385, 10.1016/j.amepre.2017.11.009 Dorff, 2007, Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient, Clin Genitourin Cancer, 5, 344, 10.3816/CGC.2007.n.016 Ellent, 2016, Metastatic prostate cancer 35 years after sex reassignment surgery, Clin Genitourin Cancer, 14, e207, 10.1016/j.clgc.2015.11.007 Turo, 2013, Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy, Can Urol Assoc J, 7, E544, 10.5489/cuaj.175 Deebel, 2017, Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges, Urology, 110, 166, 10.1016/j.urology.2017.08.032 Trum, 2015, Sex reassignment of transsexual people from a gynecologist's and urologist's perspective, Acta Obstet Gynecol Scand, 94, 563, 10.1111/aogs.12618 Gooren, 2014, Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens, Andrologia, 46, 1156, 10.1111/and.12208 Joint, 2018, Breast and reproductive cancers in the transgender population: a systematic review, BJOG, 125, 1505, 10.1111/1471-0528.15258 Sharif, 2017, The development of prostate adenocarcinoma in a transgender male to female patient: could estrogen therapy have played a role?, Prostate, 77, 824, 10.1002/pros.23322 Wang, 2017, Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5alpha-reductase 2, J Pathol, 243, 457, 10.1002/path.4985 Hembree, 2017, Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 102, 3869, 10.1210/jc.2017-01658 World professional association for transgender health, standards of care for the health of transsexual, transgender, and gender- nonconforming people. 2012. Weyers, 2010, Gynaecological aspects of the treatment and follow-up of transsexual men and women, Facts Views Vis Obgyn, 2, 35 Wesp, 2016 Islami, 2017, International trends in anal cancer incidence rates, Int J Epidemiol, 46, 924 Deshmukh, 2020, Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, J Natl Cancer Inst, 112, 829, 10.1093/jnci/djz219 Siegel, 2017, Colorectal cancer statistics, CA Cancer J Clin, 67, 177, 10.3322/caac.21395 Shiels, 2012, Impact of the HIV epidemic on the incidence rates of anal cancer in the United States, J Natl Cancer Inst, 104, 1591, 10.1093/jnci/djs371 Abbasakoor, 2005, Anal intraepithelial neoplasia, Br J Surg, 92, 277, 10.1002/bjs.4967 Tatti, 2012, Anal intraepithelial lesions in women with human papillomavirus-related disease, J Low Genit Tract Dis, 16, 454, 10.1097/LGT.0b013e31825d2d7a De Vuyst, 2009, Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis, Int J Cancer, 124, 1626, 10.1002/ijc.24116 Giuliano, 2011, Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males, N Engl J Med, 364, 401, 10.1056/NEJMoa0909537 Hillman, 2012, Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old, Clin Vaccine Immunol, 19, 261, 10.1128/CVI.05208-11 Lawton, 2013, HPV vaccination to prevent anal cancer in men who have sex with men, Sex Transm Infect, 89, 342, 10.1136/sextrans-2013-051176 Palefsky, 2011, HPV vaccine against anal HPV infection and anal intraepithelial neoplasia, N Engl J Med, 365, 1576, 10.1056/NEJMoa1010971 Center for Disease Control and Prevention. HPV Vaccination Recommendations; 2021 Available from https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html. Smittenaar, 2016, Cancer incidence and mortality projections in the UK until 2035, Br J Cancer, 115, 1147, 10.1038/bjc.2016.304 Darragh, 2011, Anal cancer and cervical cancer screening: key differences, Cancer Cytopathol, 119, 5, 10.1002/cncy.20126 Aberg, 2014, Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America, Clin Infect Dis, 58, e1, 10.1093/cid/cit665 2021 Machalek, 2012, Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis, Lancet Oncol, 13, 487, 10.1016/S1470-2045(12)70080-3 Amir, 2010, Assessing women at high risk of breast cancer: a review of risk assessment models, J Natl Cancer Inst, 102, 680, 10.1093/jnci/djq088 Johannsson, 1999, Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers, Eur J Cancer, 35, 1248, 10.1016/S0959-8049(99)00135-5 Obedin-Maliver, 2017, Time to change: supporting sexual and gender minority people-an underserved, understudied cancer risk population, J Natl Compr Canc Netw, 15, 1305, 10.6004/jnccn.2017.7050 Heshka, 2008, A systematic review of perceived risks, psychological and behavioral impacts of genetic testing, Genet Med, 10, 19, 10.1097/GIM.0b013e31815f524f Lerman, 1995, Effects of individualized breast cancer risk counseling: a randomized trial, J Natl Cancer Inst, 87, 286, 10.1093/jnci/87.4.286 Schlich-Bakker, 2006, A literature review of the psychological impact of genetic testing on breast cancer patients, Patient Educ Couns, 62, 13, 10.1016/j.pec.2005.08.012 Dieng, 2014, Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer, Psychooncology, 23, 613, 10.1002/pon.3476 Keogh, 2017, Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining, J Behav Med, 40, 583, 10.1007/s10865-016-9820-0 Rolle, 2021, Transgender patients’ perspectives on their cancer genetic counseling experiences, J Genet Couns, 00, 1